A federal judge lifted an order blocking a biosimilar of Regeneron Pharmaceuticals Inc.’s blockbuster eye drug Eylea, approving the drugmaker’s deal ending patent litigation with a pair of rivals.

(MENAFN- EIN Presswire) PowerPatent introduces its cutting-edge AI tool, Advanced Diagnostics, designed to revolutionize patent quality and strengthen IP portfolios. PowerPatent's Advanced ...

Schiltigheim, April 23th 2025 18:00, Tonner Drones is pleased to announce that its patent for the Inhibitor is granted in the USA. Tonner Drones owns the technology for an anti-recoil activation ...

We're All Ears for Celebrity Buzz! Please enter a name. Please enter a valid email. Please enter a phone number. Please enter a message. Send the Tip! Us Weekly has affiliate partnerships so we ...

Liquidia Corporation (NASDAQ:LQDA), a $1.13 billion market cap pharmaceutical company based in North Carolina, has initiated a patent infringement lawsuit against United Therapeutics (NASDAQ:UTHR) ...

It’s the NBA playoffs time again, which means the hottest ticket in town is a courtside seat. This weekend, Adele was spotted watching the Los Angeles Lakers play against the Minnesota ...

PREVIEW is an eight-issue subscription publication that provides expert, plain-language analysis of all cases given plenary review by the Supreme Court in advance of oral argument. Preview issues 1-7 ...